Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 423
Selected: 0
NCT IDTitle
NCT06725641Bioequivalence Study of Methacholine for Inhalation (pharmacodynamics)
NCT06408285A Study of TQC3927 Powder for Inhalation in Healthy Adult Subjects
NCT05213767Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB2916 Injection in Patients With Advanced Malignant Tumors
NCT06139367A Clinical Trial of TQB3454 Tablets in Healthy Adult Subjects
NCT04805060A Study to Evaluate the Tolerance and Pharmacokinetics of TQB2858 Injection in Subjects With Terminal Malignant Tumors
NCT05576480SCRT Sequential Penpulimab in Combination With CAPEOX in the Neoadjuvant Treatment of MSS Locally Advanced Rectal Cancer
NCT03855384Study of TQB2450 in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck(R/M SCCHN)
NCT04306887A Study of TQ-B3101 in Subjects With Relapsed or Refractory Anaplastic Large Cell Lymphoma (ALCL)
NCT06767813Clinical Study of TQB2868 Injection Combined With Anlotinib Capsule and Chemotherapy in the First-line Treatment of Metastatic Pancreatic Neoplasms
NCT04111913A Study of Sequential Anlotinib Followed by EP Regimen Plus Concurrent Radiotherapy for Unresectable Stage III Non-small Cell Lung Cancer
NCT03589950Anlotinib Plus Chemotherapy for Patients With Advanced Non-small Cell Lung Cancer
NCT04337879A Study of AL2846 Capsule Combined With Standard Chemotherapy Regimen in Subjects With Advanced Colorectal Cancer
NCT06754891Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease
NCT06431438Study to Evaluate the Tolerability, Safety, Pharmacokinetics and Pharmacodynamics of TQA3810 Tablets
NCT05346952A Study of TQB2450 Injection Plus Chemotherapy Followed by TQB2450 Plus Anlotinib Versus Tislelizumab Plus Chemotherapy Followed by Tislelizumab in the Treatment of First-line Non-squamous Non-small Cell Lung Cancer(NSCLC).
NCT04569838A Study to Evaluate the Efficacy and Safety of Bendamustine Hydrochloride Injection
NCT06165822A Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets
NCT04339400A Study of TQ05105 Tablets in Subjects With Myeloproliferative Neoplasms
NCT05451407Efficacy and Safety of TQB2618 Injection Combined With Toripalimab Injection in Patients With Advanced Melanoma
NCT07267130A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TQC3302 Inhalation Spray in Healthy Adult Subjects
NCT06948539To Evaluate the Tolerability and Pharmacokinetics of TQB2101 for Injection in Patients With Advanced Malignant Tumors
NCT04481607A Study to Evaluate the Tolerance, Efficacy and Pharmacokinetics of TQB3454 Tablets
NCT04836663A Study of TQ-B3525 Tablets in Subjects With PIK3CA and/or PIK3R1/2 Gene-altered Recurrent/Metastatic Advanced Gynecologic Tumors
NCT05380934A Clinical Trial of Safety and Tolerance of TQH3821 Tablets in Adult Healthy Subjects
NCT05262101Clinical Trial of TQB2858 Injection in the Treatment of Advanced High-grade Sarcoma
NCT03799601Docetaxel Combined With Carboplatin Plus Anlotinib as First Line Treatment in NSCLC
NCT05675202Material Balance Study of TQ-B3525
NCT06962267A Clinical Study on the First-line Treatment of Metastatic Pancreatic Cancer With TQB2916 Injection Combined With Gemcitabine Hydrochloride for Injection and Paclitaxel for Injection (Albumin-bound Type)
NCT07083739A Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in Adults
NCT03983928Study of TQB2450 Combined With Anlotinib in the Treatment of Mutation Positive Lung Cancer
NCT05029076Human Bioequivalence Test of Liraglutide Injection
NCT06859931Clinical Trial of TQB3702 Tablets in Subjects With Systemic Lupus Erythematosus (SLE)
NCT05032937the Accuracy and Safety of Coronary Artery Contrast-enhanced Magnetic Resonance Imaging With Polysaccharide Superparamagnetic Iron Oxide Nanoparticle
NCT06598956To Evaluate the Pharmacokinetics and Safety of TQ05105 Tablet in Renal Impairment Subjects
NCT05045872Assessment of Renal Vasculature and Function with Ferumoxytol-enhanced Magnetic Resonance Imaging
NCT06768619Bioequivalence Study of Eltrombopag Olamine Tablets in Healthy Subjects in the Fed State
NCT03771781Bioequivalence Study of Empagliflozin Tablet in Healthy Participants.
NCT02461407Study of Anlotinib in Patients With Gastric Cancer(ALTER0503)
NCT04623333A Study of TQB2450 Injection in Subjects With PD-L1 Positive Recurrent or Metastatic Cervical Cancer
NCT06475599Anlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial Cancer
NCT02403544Phase I Study of Image-Guided Radiation Concurrent With Double-Agent Chemotherapy for Hepatocellular Carcinoma
NCT06024915A Study to Evaluate Drug-Drug Interaction of TQ05105 Tablets
NCT03855358A Study of TQB2450 Injection and Anlotinib Hydrochloride Capsules to Treat Triple Negative Breast Cancer (TNBC)
NCT05834543Clinical Trial to Evaluate the Safety and Effectiveness of TQB2618 Injection Combined Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma
NCT05894421TQB2223 Injection in Combination With Penpulimab in Patients With Advanced Cancers
NCT03800706A Phase II Study to Evaluate the Safety and Efficacy of TQB2450 Injection in Relapsed or Refractory Classical Hodgkin's Lymphoma
NCT02108756Efficacy and Safety of L-Pantoprazole Sodium Injection to Treat Upper Gastrointestinal Ulcer Bleeding
NCT05610202Tolerability and Pharmacokinetics Study of TQB3702 Tablets in Hematologic Tumor Subjects
NCT05975645A Clinical Study of TQB2618 Injection Combined With Penpulimab Injection and Anlotinib Hydrochloride Capsules for First-line Treatment of Advanced Hepatocellular Carcinoma (HCC).
NCT05735496Clinical Trial of the TQB2102 Injection in Patients With Advanced Cancers